ZA972247B - Combination of enzymes for the destruction of proliferative cells. - Google Patents

Combination of enzymes for the destruction of proliferative cells.

Info

Publication number
ZA972247B
ZA972247B ZA9702247A ZA972247A ZA972247B ZA 972247 B ZA972247 B ZA 972247B ZA 9702247 A ZA9702247 A ZA 9702247A ZA 972247 A ZA972247 A ZA 972247A ZA 972247 B ZA972247 B ZA 972247B
Authority
ZA
South Africa
Prior art keywords
destruction
enzymes
combination
proliferative cells
proliferative
Prior art date
Application number
ZA9702247A
Other languages
English (en)
Inventor
Francis Blanche
Beatrice Cameron
Michel Couder
Joel Crouzet
Original Assignee
Rhone Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa
Publication of ZA972247B publication Critical patent/ZA972247B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/45—Transferases (2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • C12N9/1211—Thymidine kinase (2.7.1.21)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
ZA9702247A 1996-03-15 1997-03-14 Combination of enzymes for the destruction of proliferative cells. ZA972247B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9603267A FR2746016B1 (fr) 1996-03-15 1996-03-15 Combinaisons d'enzymes pour la destruction de cellules proliferatives

Publications (1)

Publication Number Publication Date
ZA972247B true ZA972247B (en) 1997-09-17

Family

ID=9490214

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9702247A ZA972247B (en) 1996-03-15 1997-03-14 Combination of enzymes for the destruction of proliferative cells.

Country Status (15)

Country Link
US (1) US6518062B1 (fr)
EP (1) EP0910654A1 (fr)
JP (1) JP2000507814A (fr)
KR (1) KR20000064581A (fr)
AU (1) AU732432B2 (fr)
BR (1) BR9708194A (fr)
CA (1) CA2248629A1 (fr)
CZ (1) CZ291398A3 (fr)
FR (1) FR2746016B1 (fr)
HU (1) HUP9902320A3 (fr)
IL (1) IL126154A0 (fr)
NO (1) NO984132L (fr)
SK (1) SK124598A3 (fr)
WO (1) WO1997035024A1 (fr)
ZA (1) ZA972247B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2386629A1 (fr) 1997-10-14 2011-11-16 Darwin Molecular Corporation Mutants de kinase de thymidine et protéines de fusion ayant de la kinase de thymidine et activités de kinase de guanylate
EP1914304A1 (fr) * 1998-10-14 2008-04-23 Darwin Molecular Corporation Mutants de kinase de thymidine et protéines de fusion ayant de la kinase de thymidine et activités de kinase de guanylate
GB9924981D0 (en) * 1999-10-21 1999-12-22 Univ Manchester Gene therapy
CA2342040C (fr) * 2000-09-21 2012-07-10 Kyowa Hakko Kogyo Co., Ltd. Bacterie anaerobie en tant que drogue pour la therapie genique contre le cancer
EP2322929B1 (fr) * 2000-11-27 2016-04-06 Minerva Biotechnologies Corporation Trousses et procédé diagnostiques, proédés de criblage et traitement du cancer
EP1786474B1 (fr) * 2004-08-12 2011-06-01 Cedars-Sinai Medical Center Therapie genique combinee destinee au traitement de gliomes macroscopiques
US8883493B2 (en) * 2007-01-30 2014-11-11 Cedars-Sinai Medical Center Adenoviral vector comprising herpes simplex virus type 1 thymidine kinase and a transgene for increasing the expression of the transgene
WO2016130726A1 (fr) 2015-02-10 2016-08-18 Minerva Biotechnologies Corporation Anticorps anti-muc1* humanisés
EP3287167A4 (fr) * 2015-04-24 2018-12-26 PHI Biomed Co., Ltd. Lentilles de contact intelligentes et verres intelligents
KR102303140B1 (ko) 2018-05-30 2021-09-16 이화여자대학교 산학협력단 신규 바이페닐 유도체 화합물 및 이의 용도

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0289229B1 (fr) * 1987-04-24 1992-01-29 The Wellcome Foundation Limited Mélanges antiviraux
JPH10503641A (ja) * 1994-05-02 1998-04-07 ユニバーシティ オブ ワシントン チミジンキナーゼ変異体
FR2723962B1 (fr) * 1994-08-25 1996-10-31 Univ Paris Curie Hsv1-tk modifiee fonctionnelle
US5856153A (en) 1994-11-17 1999-01-05 Cayla Suicide genes and new associations of pyrimidine nucleobase and nucleoside analogs with new suicide genes for gene therapy of acquired diseases

Also Published As

Publication number Publication date
CA2248629A1 (fr) 1997-09-25
SK124598A3 (en) 1999-03-12
WO1997035024A1 (fr) 1997-09-25
FR2746016A1 (fr) 1997-09-19
HUP9902320A2 (hu) 1999-10-28
NO984132D0 (no) 1998-09-08
AU732432B2 (en) 2001-04-26
EP0910654A1 (fr) 1999-04-28
JP2000507814A (ja) 2000-06-27
AU2164297A (en) 1997-10-10
BR9708194A (pt) 1999-07-27
US6518062B1 (en) 2003-02-11
NO984132L (no) 1998-09-08
CZ291398A3 (cs) 1998-12-16
KR20000064581A (ko) 2000-11-06
FR2746016B1 (fr) 1998-04-17
IL126154A0 (en) 1999-05-09
HUP9902320A3 (en) 2001-05-28

Similar Documents

Publication Publication Date Title
ZA9710429B (en) Broad-spectrumδ-endotoxins.
ZA976168B (en) 3-Ureido-pyridofurans and -pyridothiophenes.
AU5525998A (en) Target-triggered amplification
ZA978045B (en) New benzamidine derivatives.
ZA971272B (en) Gene expression.
ZA985026B (en) Method for enhancing the activity of an enzyme.
ZA972247B (en) Combination of enzymes for the destruction of proliferative cells.
ZA9711566B (en) Enzymatic resolution.
ZA988025B (en) Method for enhancing the activity of an enzyme.
ZA97572B (en) 1-pyrazol-3-ylethyl-4-indol-3-ylpiperidines.
GB9413419D0 (en) Amylase enzyme
ZA976022B (en) Cycloalkano-pyridines.
ZA971466B (en) Endothelin-receptor-antagonists.
GB9617184D0 (en) Enzyme
ZA972396B (en) An enzyme combination.
AU5253798A (en) Ubch7-like ubiquitin-conjugating enzyme
ZA976182B (en) Recombinant kynurenine-3-hydroxylase enzyme and process for its preparation.
PL328829A1 (en) Enzyme
ZA971474B (en) Endothelin-receptor-antagonists.
GB9617709D0 (en) Enzyme
ZA97946B (en) Burners.
ZA975469B (en) X14-mannitol.
ZA975217B (en) The handling of materials.
ZA9711116B (en) The treatment of materials.
AUPO100196A0 (en) The upper-cut ring